2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Vasculopathy, Retinal, With Cerebral Leukodystrophy: new trials by email Literature Review of Vasculopathy, Retinal, With Cerebral Leukodystrophy trials Research Report on Vasculopathy, Retinal, With Cerebral Leukodystrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Crizanlizumab for Treatment of Retinal Vasculopathy With Cerebral Leukoencephalopathy (RVCL) Crizanlizumab - RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy | Phase 2 | Completed | Washington University School of Medicine | 18 | 2021-01-25 | 2026-04-23 |
| Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy aclarubicin - Vasculopathy, Retinal, With Cerebral Leukodystrophy, Cerebroretinal Vasculopathy, Hereditary | Phase 1 | Completed | Washington University School of Medicine | 4 | 2016-12-05 | 2020-11-19 |
Aclarubicin (1) · crizanlizumab (1)
Washington University School of Medicine (2)
United States (2)
Andria Ford, MD (1) · John P Atkinson, MD (1)